Preparing patients with breast cancer for brachytherapy
Mast, D.E.; Mood, D.W.
Oncology Nursing Forum 17(2): 267-270
1990
ISSN/ISBN: 0190-535X PMID: 2315190 Document Number: 355446
Document emailed within 1 workday
Related Documents
Inoue, T.; Inoue, T.; Yoshioka, Y.; Yoshida, K. 2000: High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 3. Comparative study of early mucosal reaction and late tongue atrophy between LDR and HDR Ir-192 interstitial brachytherapy for patients with carcinoma of the mobile tongue Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 296-300Janaki, M.G.; Nirmala, S.; Kadam, A.R.; Ramesh, B.S.; Sunitha, K.S. 2008: Epidural analgesia during brachytherapy for cervical cancer patients Journal of Cancer Research and Therapeutics 4(2): 60-63
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747
2015: (P074) the use of stereotactic body radiotherapy in lieu of brachytherapy in patients with cervical or endometrial cancer Oncology 29(4 Suppl. 1)
Keats, S. 2010: High-dose rate brachytherapy in prostate cancer patients--a study on nausea and vomiting Urologic Nursing 30(3): 195-202
Makarewicz, R.; Kuźmińska, A. 1996: Use of intraluminal brachytherapy for treatment of patients with non-small cell lung cancer in cases of local failure after teleradiotherapy Pneumonologia i Alergologia Polska 64(7-8): 444-449
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82
Ansquer, Y.; Gautier, C.; Fourquet, A.; Asselain, B.; Stoppa-Lyonnet, D. 1998: Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group Lancet 352(9127): 541
Hooning, M.J.; van Dongen, J.A.; Went, G. 1991: Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation Netherlands Journal of Surgery 43(4): 102-104
Abdalla, I.; Thisted, R.A.; Heimann, R. 2000: The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy Cancer Journal 6(4): 266-272
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. I. Prognostic factors in patients with node-negative (N0) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 159-163
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. II. Prognostic factors in patients with node-positive (N1-3) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 165-170
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Li, Y.-h.; Tie, J.; Wu, H.; Li, X.-f.; Xu, B.; Cai, Y. 2013: Clinical observation of accelerated partial-breast intensity-modulated radiotherapy in patients with early-stage breast cancer after breast-conserving surgery Zhonghua Yi Xue Za Zhi 93(12): 924-926
Schultz, D.C.; Bazel, S.; Wright, L.M.; Tucker, S.; Lange, M.K.; Tachovsky, T.; Longo, S.; Niedbala, S.; Alhadeff, J.A. 1994: Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls Cancer Research 54(1): 48-54
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Taguchi, T.; Koyama, H.; Yayoi, K.; Wada, T.; Takatsuka, Y.; Sonoo, H.; Morimoto, K.; Tominaga, T.; Abe, R.; Enomoto, K. 1995: Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 495-508
Palencia, C.; Wicke, L.; Kärcher, K.H.; Gitsch, E.; Hernuss, P.; Steffen, C. 1976: Studies on the immune status of patients with operated and irradiated cervical and breast cancer. III. Comparative investigation of the immune status of patients with breast cancer treated by operation and irradiation and of patients with cervical cancer treated either by operation or irradiation Wiener Klinische Wochenschrift 88(15): 495-501
Takagi, I. 1988: Afterloading interstitial brachytherapy combined with external radiation and surgery in the treatment of locally far-advanced lung cancer and esophageal cancer Nihon Kyobu Geka Gakkai 36(10): 2200-2212